You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Azacitidine and Venetoclax

Showing 1 - 25 of 804
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Lyon, France
    Centre Léon Bérard
Nov 30, 2023

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M.D. Anderson Cancer Center
Apr 17, 2023

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)

Not yet recruiting
  • Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 10, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 20, 2023

AML, Adult, Minimal Residual Disease Trial (MRD assessment)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • MRD assessment
  • (no location specified)
Oct 13, 2023

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

Recruiting
  • Refractory/Relapse Acute Myeloid Leukemia
  • Kunming, Yunnan, China
    Department of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023

Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Pharmacokinetic sampling
  • +3 more
  • Marseille, France
  • +1 more
Sep 6, 2023

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)

Not yet recruiting
  • AML, Adult
  • Hangzhou, China
  • +3 more
Feb 12, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Myeloid Leukemia Trial in Kunming (Venetoclax in Combination With Azacitidine and HA Regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax in Combination With Azacitidine and HA Regimen
    • Kunming, Yunnan, China
      The Second Affiliated Hospital of Kunming Medical University.
    Jul 10, 2023

    Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • Aurora, Colorado
      Universtiy of Colorado Hospital
    Aug 22, 2022

    Acute Myeloid Leukemia, Adult Trial in Houston (ADI-PEG 20)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • ADI-PEG 20
    • Houston, Texas
      MD Anderson Cancer Center
    Sep 29, 2022

    Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Azacitidine and Venetoclax
    • Aurora, Colorado
      University of Colorado Denver
    Aug 1, 2022

    Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

    Recruiting
    • Secondary Myelodysplastic Syndrome
    • Therapy-Related Myelodysplastic Syndrome
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 1, 2022

    Acute Myeloid Leukemia Trial in Chicago (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Chicago, Illinois
      Northwestern University
    Feb 16, 2023

    Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Venetoclax plus Azacitidine
    • standard of care chemotherapy plus gemtuzumab ozogamicin
    • Essen, NRW, Germany
    • +17 more
    Jun 6, 2023

    Secondary Acute Myeloid Leukemia Trial in Nanjing (Venetoclax;Azacitidine;Homoharringtonine)

    Recruiting
    • Secondary Acute Myeloid Leukemia
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Aug 21, 2022

    Acute Myeloid Leukemia Trial in Sacramento (Azacitidine, Uproleselan, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Aug 12, 2022

    Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

    Recruiting
    • Hypomethylating Agent
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University School of Medicine Affilated Shang
    May 2, 2023